Alexander Riad
Teterow, MV, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
High-Mobility Group Box Protein 1 Is an Independent Prognostic Marker for All-Cause Mortality in Patients With Dilated Cardiomyopathy.
Journal: The American journal of cardiology
Published: January 27, 2022
Myeloid differentiation factor-2 activates monocytes in patients with dilated cardiomyopathy.
Journal: Immunology
Published: September 26, 2021
MD-2 is a new predictive biomarker in dilated cardiomyopathy and exerts direct effects in isolated cardiomyocytes.
Journal: International journal of cardiology
Published: March 07, 2018
The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
Journal: European journal of pharmacology
Published: April 27, 2015
Multicenter long-term validation of a minicourse in radiation-reducing techniques in the catheterization laboratory.
Journal: The American journal of cardiology
Published: July 28, 2014
ECG-gated coronary angiography enables submillisievert imaging in invasive cardiology.
Journal: Herz
Published: July 19, 2014
Stiffness of left ventricular cardiac fibroblasts is associated with ventricular dilation in patients with recent-onset nonischemic and nonvalvular cardiomyopathy.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: June 06, 2014
Innate immune receptors in heart failure: Side effect or potential therapeutic target?
Journal: World journal of cardiology
Published: January 15, 2014
Efficacy of a minicourse in radiation-reducing techniques in invasive cardiology: a multicenter field study.
Journal: JACC. Cardiovascular interventions
Published: August 08, 2013
Latest-generation catheterization systems enable invasive submillisievert coronary angiography.
Journal: Herz
Published: August 07, 2013
Variants of Toll-like receptor 4 predict cardiac recovery in patients with dilated cardiomyopathy.
Journal: The Journal of biological chemistry
Published: May 31, 2012
Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.
Journal: Circulation
Published: October 12, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026